CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Boiron SA Company Snapshot
Boiron SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Boiron SA with three other companies in this sector in France: Vetoquinol Sa (2018 sales of 367.90 million Euro [US$414.30 million] ), Guerbet SA (789.60 million Euro [US$889.19 million] ), and Virbac (868.80 million Euro [US$978.38 million] ).

Sales Analysis. During the year ended December of 2018, sales at Boiron SA were 604.21 million Euro (US$680.42 million). This is a decrease of 2.2% versus 2017, when the company's sales were 617.54 million Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Boiron SA had sales of 617.73 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Boiron SA
  Stock Performance Chart for Boiron SA
 
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 50.10
(Figures in Euro)
1 Week -0.2%   13 Weeks -2.3%  
4 Weeks -5.1%   52 Weeks -27.1%  
 
Boiron SA Key Data:
  Ticker: BOI Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 604,212,000
(Year Ending Jan 2019).
Employees: 3,718
  Currency: Euro Market Cap: 881,926,683
  Fiscal Yr Ends: December Shares Outstanding: 17,603,327
  Share Type: Actions Ordinaries Closely Held Shares: 13,164,779
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.